Liberate Bio taps former AZ drug-delivery head for CEO post
C-suite additions at Boston-based Liberate Bio also include the appointment of a new chief scientific officer.
Stay updated with breaking news from Walter Strapps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
C-suite additions at Boston-based Liberate Bio also include the appointment of a new chief scientific officer.
David Regan provides an update on Sona Nanotech’s agreement with Siva Therapeutics to develop gold nanorod therapies for treating cancer
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021 Halifax, Nova
Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.